312 related articles for article (PubMed ID: 27426872)
1. Managing renal complications in multiple myeloma.
Fotiou D; Dimopoulos MA; Kastritis E
Expert Rev Hematol; 2016 Sep; 9(9):839-50. PubMed ID: 27426872
[TBL] [Abstract][Full Text] [Related]
2. Current treatments for renal failure due to multiple myeloma.
Gavriatopoulou M; Terpos E; Kastritis E; Dimopoulos MA
Expert Opin Pharmacother; 2016 Nov; 17(16):2165-2177. PubMed ID: 27646819
[TBL] [Abstract][Full Text] [Related]
3. Current treatments for renal failure due to multiple myeloma.
Kastritis E; Terpos E; Dimopoulos MA
Expert Opin Pharmacother; 2013 Aug; 14(11):1477-95. PubMed ID: 23705905
[TBL] [Abstract][Full Text] [Related]
4. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.
Finkel KW; Cohen EP; Shirali A; Abudayyeh A;
Clin J Am Soc Nephrol; 2016 Dec; 11(12):2273-2279. PubMed ID: 27526708
[TBL] [Abstract][Full Text] [Related]
5. Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry.
Ho PJ; Moore EM; McQuilten ZK; Wellard C; Bergin K; Augustson B; Blacklock H; Harrison SJ; Horvath N; King T; Mollee P; Quach H; Reid C; Rosengarten B; Walker P; Wood EM; Spencer A
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e415-e424. PubMed ID: 31208889
[TBL] [Abstract][Full Text] [Related]
6. Current Trends of Renal Impairment in Multiple Myeloma.
Yadav P; Cook M; Cockwell P
Kidney Dis (Basel); 2016 Mar; 1(4):241-57. PubMed ID: 27536684
[TBL] [Abstract][Full Text] [Related]
7. [Renal disease in multiple myeloma].
Hiromura K; Nojima Y
Nihon Rinsho; 2007 Dec; 65(12):2229-34. PubMed ID: 18069265
[TBL] [Abstract][Full Text] [Related]
8. Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
Ueda H; Kuno H; Takahashi D; Katsuma A; Kimura A; Nakashima A; Kato J; Momoki M; Ohba R; Dobashi N; Yamamoto I; Kawamura T; Miyazaki Y; Yokoo T
CEN Case Rep; 2020 May; 9(2):165-172. PubMed ID: 31974826
[TBL] [Abstract][Full Text] [Related]
9. Myeloma kidney: improving clinical outcomes?
Haynes R; Leung N; Kyle R; Winearls CG
Adv Chronic Kidney Dis; 2012 Sep; 19(5):342-51. PubMed ID: 22920645
[TBL] [Abstract][Full Text] [Related]
10. [Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma].
de Alarcón Jiménez RM; Roca Meroño S; Alvarez Fernández GM; García Hernández MA; Navarro Parreño MJ; Jimeno Griñó C; Zarco Pedrinaci E; Molina Núñez M
Nefrologia; 2011; 31(2):238-40. PubMed ID: 21461027
[No Abstract] [Full Text] [Related]
11. [Expert consensus for the diagnosis and treatment of patients with renal impairment of multiple myeloma].
Renal Impairment of Multiple Myeloma Collaborative Study Group
Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):871-875. PubMed ID: 29136724
[TBL] [Abstract][Full Text] [Related]
12. [Multiple myeloma and renal impairment].
Takahashi N
Nihon Rinsho; 2015 Jan; 73(1):38-41. PubMed ID: 25626301
[TBL] [Abstract][Full Text] [Related]
13. Management of myeloma-associated renal dysfunction in the era of novel therapies.
Gaballa MR; Laubach JP; Schlossman RL; Redman K; Noonan K; Mitsiades CS; Ghobrial IM; Munshi N; Anderson KC; Richardson PG
Expert Rev Hematol; 2012 Feb; 5(1):51-66; quiz 67-8. PubMed ID: 22272706
[TBL] [Abstract][Full Text] [Related]
14. Renal failure in multiple myeloma: a medical emergency.
Wirk B
Bone Marrow Transplant; 2011 Jun; 46(6):771-83. PubMed ID: 21339749
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency.
Tosi P; Zamagni E; Tacchetti P; Ceccolini M; Perrone G; Brioli A; Pallotti MC; Pantani L; Petrucci A; Baccarani M; Cavo M
Biol Blood Marrow Transplant; 2010 Aug; 16(8):1115-21. PubMed ID: 20197100
[TBL] [Abstract][Full Text] [Related]
16. Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal Impairment.
Sharma R; Jain A; Jandial A; Lad D; Khadwal A; Prakash G; Nada R; Aggarwal R; Ramachandran R; Varma N; Malhotra P
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):626-634. PubMed ID: 35610119
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of autologous hemopoietic progenitor cell collection in tandem with hemodialysis in multiple myeloma with myeloma cast nephropathy.
Weinstein R; Kershaw G; Bailey J; Greene M; Chhibber V; Vauthrin M; Nath R; Galvin Karr E
J Clin Apher; 2014 Apr; 29(2):83-9. PubMed ID: 23959911
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Efficacy and Cost Effectiveness of High Cut-Off Dialyzers Compared to Conventional Dialysis in Patients with Cast Nephropathy.
Curti A; Schwarz A; Trachsler J; Tomonaga Y; Ambühl PM
PLoS One; 2016; 11(7):e0159942. PubMed ID: 27467401
[TBL] [Abstract][Full Text] [Related]
19. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.
Dimopoulos MA; Terpos E; Chanan-Khan A; Leung N; Ludwig H; Jagannath S; Niesvizky R; Giralt S; Fermand JP; Bladé J; Comenzo RL; Sezer O; Palumbo A; Harousseau JL; Richardson PG; Barlogie B; Anderson KC; Sonneveld P; Tosi P; Cavo M; Rajkumar SV; Durie BG; San Miguel J
J Clin Oncol; 2010 Nov; 28(33):4976-84. PubMed ID: 20956629
[TBL] [Abstract][Full Text] [Related]
20. [Improved prognosis in light chain nephropathy due to multiple myeloma].
Juul JS; Larsen T; Marcussen N; Pedersen EB
Ugeskr Laeger; 2012 Apr; 174(17):1159-60. PubMed ID: 22533933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]